Charter Capital Partners, a Grand Rapids, Michigan-based investment bank, announced that its client, Devana Solutions (Devana), has been acquired by RealTime Software Solutions (RealTime), a portfolio company of LLR Partners. An innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and site-based clinicians, Devana serves patients in diverse communities. Its platform bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trial systems.RealTime is a leading provider of cloud-based software solutions for the clinical research industry, providing innovative software solutions for clinical research sites, site networks, sponsors and CROs to manage complex clinical research processes with powerful, user-friendly interfaces. This strategic move delivers the most comprehensive and advanced end-to-end site platform available to the market. The combined expertise and capabilities of RealTime and Devana will propel the industry forward and set a new standard for end-to-end site platforms."RealTime recognized the opportunity to integrate our complementary technologies and improve the clinical trial process when Devana Solutions was just launching," said Barry Lake, CEO and Co-Founder of Devana. "Our customers and study participants are the real winners today, as the Devana and RealTime cultures are completely aligned and dedicated to supporting our customers' efforts to expedite therapeutic advancements for study participants."Mike Palm, Partner and Managing Director at Charter Capital Partners, and Zach Wiersma, Vice President, spearheaded the deal process for Devana. “The Charter team was delighted to help combine Devana and Realtime’s businesses,” stated Palm. “They are incredibly complementary in their service offering to the clinical trial space.” Wiersma added, “Barry and his team have built an impressive SaaS business and we were excited to work with them to a successful close.”"Devana's platform perfectly complements our already robust suite of clinical trial software solutions," said Stephen Johnson, CEO of RealTime. "Devana has been a trusted partner since 2018, offering CTMS-integrated study startup and pipeline administration capabilities that streamline data collection by eliminating the need to input critical study information into separate systems."By integrating Devana's solutions into RealTime's Site Operations Management System (SOMS), clinical research organizations will gain access to an unparalleled suite of capabilities that bridge centralized operations with site-based clinical teams. The combination of these solutions establishes seamless connectivity between Devana's industry-leading business development and data analytics platform and RealTime's fully integrated suite of products that includes CTMS, eRegulatory solutions, eSource, eConsent, Payments, Texting solutions, the MyStudyManager Participant Portal and other eClinical solutions and services.Originally designed to address the operational gap before participant recruitment, screening and CTMS-managed clinical workflows, Devana's PROPEL products automate pipeline management and trial startup workflows while capturing timing and performance metrics for analysis and action. By connecting centralized research professionals with decentralized site-based clinicians, Devana's platform enhances efficiency in site network operations. PROPEL has garnered significant adoption by the leading site-focused research organizations in the world.With this acquisition, RealTime reinforces its commitment to delivering innovative solutions that empower the clinical research industry and further streamline the development of life-changing treatments. The combined expertise and capabilities of RealTime and Devana will propel the industry forward and set a new standard for end-to-end site platforms.